Amount Raised
$650 Million
Round Type
Post-IPO Equity
Foster CityBiotechnologyHealthcareTherapeuticsPharmaceuticalBiopharmaInvestors
Description
On December 9, 2025, Terns Pharmaceuticals, Inc. entered into an underwriting agreement for a public offering of 16,250,000 shares of its common stock. The underwriters were granted an option to purchase an additional 2,437,500 shares, which they exercised in full on December 10, 2025. This offering is aimed at strengthening the company's financial position and funding its ongoing development activities
Quick answer
Terns Pharmaceuticals raised $650 Million in a Post-IPO Equity round, dated December 11, 2025. Investors: Leerink Partners LLC, TD Securities (USA) LLC and Jefferies LLC. Terns Pharmaceuticals is based in Foster City, California, United States.
- How much did Terns Pharmaceuticals raise?
- Terns Pharmaceuticals raised $650 Million in a Post-IPO Equity round on December 11, 2025.
- Who invested in Terns Pharmaceuticals?
- Leerink Partners LLC, TD Securities (USA) LLC and Jefferies LLC are named as investors in this round.
- What does Terns Pharmaceuticals do?
- Terns Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology, obesity and NASH.
- Where is Terns Pharmaceuticals based and how big is it?
- Terns Pharmaceuticals is based in Foster City, California, United States. Fundz records about 64 employees.
- Who are the decision-makers at Terns Pharmaceuticals?
- Fundz holds 2 contacts at Terns Pharmaceuticals, including the Media Contact. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Healthcare and Therapeutics around the same time
Companies in the same sectors as Terns Pharmaceuticals that raised within 45 days of this round, from Fundz verified event records.
- Os Therapies raised $3.5M on January 14, 2026.
- Parabilis Medicines raised $305M (Series F) on January 8, 2026.
- CASI Pharmaceuticals raised $5M on December 27, 2025.
- Kymera Therapeutics raised $602M (Post-IPO Equity) on December 10, 2025.
- Citius Oncology raised $18M (Funding Round) on December 9, 2025.
- Azora Therapeutics, Inc. (DE) raised $4.3M on November 28, 2025.
Who to call at Terns Pharmaceuticals, and when
A new round usually means Terns Pharmaceuticals is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Terns Pharmaceuticals raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Terns Pharmaceuticals, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Terns Pharmaceuticals. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Terns Pharmaceuticals raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Terns Pharmaceuticals raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.